Nkarta (NKTX) EBITDA (2019 - 2026)
Nkarta's (NKTX) quarterly EBITDA came in at -$30.9 million in Q1 2026, up 15.56% year-on-year from -$26.7 million in Q1 2025, and little changed quarter-over-quarter from -$31.0 million in Q4 2025.
Nkarta (NKTX) EBITDA (2019 - 2026) Analysis & Trends
Nkarta's EBITDA history runs 8 years deep, the most recent figure standing at -$30.9 million for Q1 2026.
- On a quarterly basis, EBITDA rose 15.56% year-over-year to -$30.9 million in Q1 2026; TTM through Mar 2026 was -$116.3 million, a 11.88% increase from a year earlier, with the FY2025 full-year figure at -$122.0 million, up 4.83% from the prior year.
- EBITDA was little changed at -$30.9 million in Q1 2026 per NKTX's latest filing, from -$31.0 million in the prior quarter.
- Across five years, EBITDA topped out at -$26.1 million in Q1 2022 and bottomed at -$36.9 million in Q2 2023.
- The 5-year median for EBITDA is -$30.9 million (2024), against an average of -$31.3 million.
- Across the five-year window, EBITDA sank 52.85% in 2022 and increased 19.26% in 2025, its largest moves.
- Year by year, EBITDA stood at -$35.0 million in 2022, then climbed by 10.86% to -$31.2 million in 2023, then gained by 0.84% to -$30.9 million in 2024, then declined by 0.12% to -$31.0 million in 2025, then climbed by 0.27% to -$30.9 million in 2026.
- Per Business Quant, the three latest NKTX EBITDA figures stand at -$30.9 million (Q1 2026), -$31.0 million (Q4 2025), and -$27.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - | -30.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.88 Mn |
| Dec 31, 2025 | -30.96 Mn |
| Sep 30, 2025 | -27.29 Mn |
| Jun 30, 2025 | -27.19 Mn |
| Mar 31, 2025 | -36.56 Mn |
| Dec 31, 2024 | -30.92 Mn |
| Sep 30, 2024 | -33.79 Mn |
| Jun 30, 2024 | -30.72 Mn |
| Mar 31, 2024 | -32.76 Mn |
| Dec 31, 2023 | -31.19 Mn |
| Sep 30, 2023 | -29.29 Mn |
| Jun 30, 2023 | -36.86 Mn |
| Mar 31, 2023 | -34.31 Mn |
| Dec 31, 2022 | -34.98 Mn |
| Sep 30, 2022 | -30.26 Mn |
| Jun 30, 2022 | -27.61 Mn |
| Mar 31, 2022 | -26.10 Mn |
| Dec 31, 2021 | -22.89 Mn |
| Sep 30, 2021 | -22.43 Mn |
| Jun 30, 2021 | -21.63 Mn |